Spectroscopic and molecular docking studies reveal binding characteristics of nazartinib (EGF816) to human serum albumin

The interactions of novel anti-cancer therapeutic agents with the different plasma and tissue components, specifically serum albumins, have lately gained considerable attention due to the significant influence of such interactions on the pharmacokinetics and/or -dynamics of this important class of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Almehizia, Abdulrahman A., AlRabiah, Haitham, Bakheit, Ahmed H., Hassan, Eman S. G., Herqash, Rashed N., Abdelhameed, Ali Saber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029911/
https://www.ncbi.nlm.nih.gov/pubmed/32218978
http://dx.doi.org/10.1098/rsos.191595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029911/
https://www.ncbi.nlm.nih.gov/pubmed/32218978
http://dx.doi.org/10.1098/rsos.191595

Ejemplares similares